Triazole derivatives as Wnt signaling pathway inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403812
APP PUB NO 20150322057A1
SERIAL NO

14753537

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSLO UNIVERSITY HOSPITAL HFC/O HELSE SOR OST GREV WEDELS PLASS 5 OSLO N-0151

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Holsworth, Daniel San Diego, US 5 55
Krauss, Stefan Eidsvoll verk, NO 27 136
Machon, Ondrej Prague, CZ 3 55
Voronkov, Andrey Edward Oslo, NO 2 13
Waaler, Jo Oslo, NO 5 55

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00